Moleculin Biotech, Inc. - 8-K Filing
Moleculin Biotech executed a 1-for-20 reverse stock split effective October 20, 2026. (Items: 3.03 Material Modifications of Rights of Security Holders, 8.01 Other Events On October 16, 2026, the Company issued a press release to announce that it filed a certificate of amendment to its certificate, 9.01 Financial Statements and Exhibits)
Tickers: $MBRX
Read the full article at SEC EDGAR
Part of the story PharmaCyte Biotech, Inc. - 8-K Filing (2 articles)